Stocks Overview

LAST PRICE
59.5300
TODAY'S CHANGE (%)
Trending Down-0.3900 (-0.6509%)

Bid / Lots
58.8000/ 1
Ask / Lots
59.4900/ 1
Open / Previous Close
59.6200 / 59.9200
Day Range
Low 58.6400
High 60.4700
52 Week Range
Low 25.9800
High 110.2500
Volume
1,056,744
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 59.92
Time	Volume	CYTK
09:32 ET	23223	59.71
09:34 ET	600	59.72
09:36 ET	1000	59.615
09:38 ET	350	59.6
09:39 ET	400	59.5
09:41 ET	600	59.3224
09:43 ET	300	59.41
09:48 ET	400	59.52
09:50 ET	1465	59.435
09:52 ET	100	59.3681
09:54 ET	200	59.37
09:56 ET	1451	59.33
09:57 ET	1136	59.25
09:59 ET	600	59.35
10:01 ET	700	59.32
10:03 ET	523	59.28
10:06 ET	800	59.2
10:08 ET	400	59.18
10:10 ET	6920	59.08
10:12 ET	4527	59.065
10:14 ET	2000	59.07
10:15 ET	462	59.105
10:17 ET	1100	59.1
10:19 ET	300	59.03
10:21 ET	1800	59
10:24 ET	1100	59.15
10:26 ET	400	59.03
10:28 ET	300	59
10:30 ET	2193	59.075
10:32 ET	3047	59.1
10:33 ET	1400	59.0425
10:35 ET	1463	59
10:37 ET	1120	59.0415
10:39 ET	4310	59.01
10:42 ET	3320	59.07
10:44 ET	1627	59.39
10:46 ET	500	59.225
10:48 ET	1800	59.25
10:50 ET	34027	59.03
10:51 ET	13326	59.24
10:53 ET	2624	59.235
10:55 ET	4842	59.34
10:57 ET	3441	59.61
11:00 ET	8716	59.51
11:02 ET	7321	59.7899
11:04 ET	4760	59.7
11:06 ET	414	59.54
11:09 ET	672	59.5
11:11 ET	8436	59.39
11:13 ET	300	59.5
11:15 ET	2627	59.52
11:18 ET	1200	59.615
11:20 ET	1458	59.61
11:22 ET	3850	59.78
11:24 ET	13670	60.07
11:26 ET	10093	60.025
11:27 ET	3663	60.38
11:29 ET	7039	60.2
11:31 ET	6594	59.81
11:33 ET	1534	59.68
11:36 ET	806	59.565
11:38 ET	932	59.52
11:40 ET	2500	59.65
11:42 ET	900	59.615
11:44 ET	8944	59.72
11:45 ET	1461	59.78
11:47 ET	1100	59.68
11:49 ET	1117	59.665
11:51 ET	1300	59.74
11:54 ET	2500	59.7
11:56 ET	1600	59.6246
11:58 ET	1000	59.81
12:00 ET	400	59.74
12:02 ET	5850	60.1
12:03 ET	3877	60.35
12:05 ET	4067	60.41
12:07 ET	3113	60.17
12:09 ET	1600	60.14
12:12 ET	400	60
12:14 ET	307	59.855
12:16 ET	1337	59.71
12:18 ET	2224	59.76
12:20 ET	1963	59.73
12:21 ET	1292	59.63
12:23 ET	634	59.575
12:25 ET	1407	59.575
12:27 ET	903	59.57
12:30 ET	2551	59.685
12:32 ET	400	59.799
12:34 ET	300	59.69
12:36 ET	600	59.64
12:38 ET	1800	59.65
12:39 ET	943	59.765
12:41 ET	500	59.65
12:43 ET	1024	59.65
12:45 ET	1307	59.625
12:48 ET	4469	59.55
12:50 ET	6575	59.655
12:54 ET	600	59.805
12:56 ET	400	59.62
12:57 ET	1156	59.6
12:59 ET	200	59.62
01:01 ET	481	59.6
01:06 ET	928	59.64
01:08 ET	428	59.625
01:10 ET	663	59.6
01:12 ET	100	59.71
01:14 ET	487	59.67
01:15 ET	1134	59.78
01:17 ET	100	59.73
01:19 ET	600	59.64
01:21 ET	400	59.62
01:24 ET	600	59.69
01:28 ET	100	59.705
01:30 ET	793	59.67
01:32 ET	200	59.65
01:33 ET	300	59.7
01:35 ET	900	59.675
01:37 ET	300	59.63
01:39 ET	2242	59.92
01:42 ET	300	59.96
01:44 ET	100	59.87
01:46 ET	920	59.87
01:48 ET	400	59.865
01:50 ET	100	59.865
01:51 ET	300	59.865
01:53 ET	3954	59.64
01:55 ET	499	59.6
01:57 ET	3480	59.565
02:00 ET	120	59.6
02:02 ET	1171	59.66
02:04 ET	700	59.565
02:06 ET	486	59.555
02:08 ET	2500	59.565
02:09 ET	400	59.6
02:11 ET	100	59.585
02:13 ET	5065	59.68
02:15 ET	13560	59.6
02:18 ET	1239	59.615
02:20 ET	100	59.615
02:22 ET	1258	59.65
02:24 ET	2172	59.59
02:26 ET	400	59.55
02:27 ET	600	59.56
02:29 ET	600	59.65
02:31 ET	3501	59.7
02:33 ET	1133	59.71
02:36 ET	200	59.68
02:38 ET	900	59.7
02:40 ET	300	59.73
02:44 ET	300	59.74
02:45 ET	550	59.7
02:47 ET	900	59.74
02:49 ET	500	59.72
02:54 ET	600	59.74
02:56 ET	2450	59.83
02:58 ET	650	59.79
03:00 ET	600	59.8
03:02 ET	917	59.8
03:03 ET	1200	59.75
03:05 ET	12782	59.605
03:07 ET	2000	59.63
03:09 ET	300	59.61
03:12 ET	1965	59.71
03:14 ET	200	59.69
03:16 ET	100	59.675
03:18 ET	2200	59.675
03:20 ET	100	59.67
03:21 ET	1142	59.62
03:23 ET	1611	59.64
03:25 ET	500	59.655
03:27 ET	1111	59.63
03:30 ET	1871	59.63
03:32 ET	6698	59.7416
03:34 ET	2158	59.64
03:36 ET	3309	59.69
03:38 ET	3103	59.675
03:39 ET	2706	59.765
03:41 ET	3807	59.75
03:43 ET	8157	59.6
03:45 ET	4241	59.67
03:48 ET	3792	59.625
03:50 ET	9901	59.43
03:52 ET	4580	59.72
03:54 ET	5505	59.735
03:56 ET	9375	59.6
03:57 ET	16603	59.47
03:59 ET	20244	59.53

Data delayed at least 15 minutes.

Today
- Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
May 15, 2024
- Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024, from 7:30AM ET on Wednesday May 15, 2024 by Dow Jones
  7:30AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
- DJ Cytokinetics Price Target Maintained With a $106.00/Share by JMP Securities, from 1:35PM ET on Tuesday May 14, 2024 by Dow Jones
  1:35PM ET on Tuesday May 14, 2024 by Dow Jones
- DJ Cytokinetics Price Target Maintained With a $94.00/Share by HC Wainwright & Co., from 7:27AM ET on Tuesday May 14, 2024 by Dow Jones
  7:27AM ET on Tuesday May 14, 2024 by Dow Jones
- DJ Cytokinetics Price Target Maintained With a $108.00/Share by Needham, from 5:44AM ET on Tuesday May 14, 2024 by Dow Jones
  5:44AM ET on Tuesday May 14, 2024 by Dow Jones

1 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCYTK Cytokinetics Inc	6.3B	-11.0x	---
United StatesRVMD Revolution Medicines Inc	6.4B	-10.5x	---
United StatesBBIO BridgeBio Pharma Inc	5.8B	-9.3x	---
United StatesIBRX Immunitybio Inc	5.4B	-7.3x	---
United StatesVKTX Viking Therapeutics Inc	7.6B	-72.0x	---
United StatesCERE Cerevel Therapeutics Holdings Inc	7.7B	-15.5x	---
As of 2024-05-17

Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company specializes in muscle biology and the mechanics of muscle performance. It is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. Its cardiac muscle contractility program is focused on the cardiac sarcomere. Its clinical-stage drug candidates are: aficamten, which is a next-in-class cardiac myosin inhibitor; omecamtiv mecarbil, which is a cardiac myosin activator; CK-586, which is an additional cardiac myosin inhibitor, and CK-136, which is a cardiac troponin activator. CK-586 is designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction.

Contact Information

Headquarters: 350 Oyster Point BoulevardSOUTH SAN FRANCISCO, CA, United States 94080
Phone: 650-624-3000
Fax: 650-624-3010

Executives

Independent Chairman of the Board: John Henderson
President, Chief Executive Officer, Principal Financial Officer, Director: Robert Blum
Chief Financial Officer, Executive Vice President: Sung Lee
Executive Vice President, Chief Commercial Officer: Andrew Callos
Executive Vice President - Research and Development: Fady Malik

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$6.3B
Revenue (TTM)	$3.8M
Shares Outstanding	104.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.78
EPS	$-5.40
Book Value	$-3.80
P/E Ratio	-11.0x
Price/Sales (TTM)	1,674.5
Price/Cash Flow (TTM)	---
Operating Margin	-13,272.04%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Cytokinetics Inc
NASDAQ:CYTKUnited States

Search Criteria

Charts

Recent News

Today

Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology, from 12 hours ago by Dow Jones

May 15, 2024

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024, from 7:30AM ET on Wednesday May 15, 2024 by Dow Jones

May 14, 2024

DJ Cytokinetics Price Target Maintained With a $106.00/Share by JMP Securities, from 1:35PM ET on Tuesday May 14, 2024 by Dow Jones

DJ Cytokinetics Price Target Maintained With a $94.00/Share by HC Wainwright & Co., from 7:27AM ET on Tuesday May 14, 2024 by Dow Jones

DJ Cytokinetics Price Target Maintained With a $108.00/Share by Needham, from 5:44AM ET on Tuesday May 14, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar